Last quarter (Q4 2023), Medicine Man Technologies's total revenue was $43.32M, a decrease of ― from the same quarter last year. In Q4, Medicine Man Technologies's net income was $-31.59M. See Medicine Man Technologies’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 166.78M	$ 172.45M	$ 142.95M	$ 116.93M	$ 26.59M	$ -325.59K
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Income	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Non Operating Interest Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ -14.81M	$ -14.81M	$ -3.57M	$ 18.92M	$ -20.32M	$ -17.56M
Tax Provision	$ 19.74M	$ 19.74M	$ 14.90M	$ 4.40M	$ -899.11K	$ -582.93K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -42.70M	$ -42.70M	$ -26.27M	$ 7.17M	$ -19.42M	$ -16.98M
Basic EPS	$ -0.76	$ -0.66	$ -0.49	$ 0.17	$ -0.47	$ -0.50
Diluted EPS	$ -0.66	$ -0.66	$ -0.49	$ -0.06	$ -0.47	$ -0.50
Basic Average Shares	$ 258.14M	$ 64.54M	$ 53.64M	$ 43.34M	$ 41.22M	$ 33.74M
Diluted Average Shares	$ 258.14M	$ 64.54M	$ 53.64M	$ 101.37M	$ 41.22M	$ 33.74M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ -34.55M	$ -34.55M	$ -18.47M	$ 14.52M	$ -19.42M	$ -16.98M
Normalized Income	$ 11.24M	$ -27.47M	$ 9.88M	$ 14.70M	$ ―	$ ―
Interest Expense	$ 15.64M	$ ―	$ 30.14M	$ 7.01M	$ 41.46K	$ ―
EBIT	$ -3.32M	$ 17.26M	$ ―	$ ―	$ ―	$ ―
EBITDA	$ 12.07M	$ 48.40M	$ ―	$ ―	$ ―	$ ―

Currency in USD

Medicine Man Technologies Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing